Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants' vaccination against hepatitis B in general and pediatric practices - the PRALINE study.
Rev Epidemiol Sante Publique
; 64(3): 185-94, 2016 Jun.
Article
in En
| MEDLINE
| ID: mdl-27238163
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Poliovirus Vaccine, Inactivated
/
Patient Acceptance of Health Care
/
Diphtheria-Tetanus-Pertussis Vaccine
/
Public Health
/
Hepatitis B Vaccines
/
Haemophilus Vaccines
/
Hepatitis B
/
Insurance, Health, Reimbursement
Type of study:
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Determinantes_sociais_saude
/
Implementation_research
Limits:
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Rev Epidemiol Sante Publique
Year:
2016
Document type:
Article
Country of publication:
Francia